Blosozumab (Anti-SOST / Sclerostin)
Blosozumab (Anti-SOST / Sclerostin) (A2787-GRP)
Products
Description
Blosozumab (anti-SOST/ Sclerostin) is a humanized monoclonal antibody against sclerostin. Blosozumab stimulates bone formation, reduces bone resorption, and has the potential to be used in the research of osteoporosis. MW: 144.88 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2787 |